Headlines on Deadline...


Philadelphia's Jefferson Health System has threatened to drop Independence Blue Cross June 1 unless a new contract can be hammered out. Few expect that to happen — Jefferson makes up 20 percent of IBC's business, while the insurer means a quarter of Jefferson's revenue. But both sides sent letters to patients and members to frame the issues — a sign of how health systems are increasingly taking their disputes straight to the public.... Whether you're in an HMO or an indemnity plan, there's no difference in your likelihood of being hospitalized or having access problems, according to a Center for Studying Health System Change study. While that skewers the perception of HMOs as barriers to care, it raises questions about their ability to control costs.... The prospect of lower out-of-pocket costs is far more important to people who join Medicare HMOs than prescription-drug benefits, according to a study by the Office of the Inspector General... The Academy for International Health Studies has launched a feasibility study into a cross-border health plan that would cover people who work and live in the U.S. and their families living in Mexico.

Career Opportunities

HAP, a subsidiary of Henry Ford Health System, is a nonprofit health plan providing coverage to individuals, companies and organizations. This executive develops strategies to meet membership and revenue targets through products, pricing, market segmentation and advertising.  Aligns business among Business Development, Commercial Sales, Medicare and Public Sector Programs and Product Development. Seeks to enhance and be responsible for business development and expansion through the development of an effective product portfolio, strong interpersonal relationships and service excellence.

Apply via email to jfedder1@hfhs.org or online at http://p.rfer.us/HENRYFORDlXqAJA

Subscribe to Our Newsletters

Monthly table of contents

Be notified as each issue of Managed Care is available online.

Biweekly newsletter

Recent topics have included:

PTCommunity news

New drug approvals, clinical trials, drug management. Three times per week.